

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug transmembrane transport (GO:0006855) | 9.73782118 |
| 2 | lysine metabolic process (GO:0006553) | 9.13680800 |
| 3 | lysine catabolic process (GO:0006554) | 9.13680800 |
| 4 | aminoglycoside antibiotic metabolic process (GO:0030647) | 8.50607100 |
| 5 | drug transport (GO:0015893) | 8.49201138 |
| 6 | organic cation transport (GO:0015695) | 8.44790266 |
| 7 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 8.00638808 |
| 8 | phosphate ion transport (GO:0006817) | 7.61828491 |
| 9 | response to mercury ion (GO:0046689) | 7.53400321 |
| 10 | nephron tubule formation (GO:0072079) | 7.19445746 |
| 11 | cysteine metabolic process (GO:0006534) | 7.11437851 |
| 12 | * excretion (GO:0007588) | 6.70529042 |
| 13 | phosphate ion transmembrane transport (GO:0035435) | 6.58149353 |
| 14 | metanephric tubule development (GO:0072170) | 6.55706390 |
| 15 | metanephric nephron tubule development (GO:0072234) | 6.55706390 |
| 16 | iron coordination entity transport (GO:1901678) | 6.29481130 |
| 17 | quaternary ammonium group transport (GO:0015697) | 6.22635524 |
| 18 | renal absorption (GO:0070293) | 6.19167132 |
| 19 | nonribosomal peptide biosynthetic process (GO:0019184) | 6.09812322 |
| 20 | glyoxylate metabolic process (GO:0046487) | 6.05903907 |
| 21 | metanephric nephron epithelium development (GO:0072243) | 6.01426406 |
| 22 | aspartate family amino acid catabolic process (GO:0009068) | 6.00356663 |
| 23 | negative regulation of metanephros development (GO:0072217) | 5.92420187 |
| 24 | axonemal dynein complex assembly (GO:0070286) | 5.69767454 |
| 25 | polyol transport (GO:0015791) | 5.60267437 |
| 26 | metanephric epithelium development (GO:0072207) | 5.58488015 |
| 27 | glutathione biosynthetic process (GO:0006750) | 5.56987986 |
| 28 | indole-containing compound catabolic process (GO:0042436) | 5.51422416 |
| 29 | indolalkylamine catabolic process (GO:0046218) | 5.51422416 |
| 30 | tryptophan catabolic process (GO:0006569) | 5.51422416 |
| 31 | pattern specification involved in kidney development (GO:0061004) | 5.47948679 |
| 32 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 5.40645094 |
| 33 | 2-oxoglutarate metabolic process (GO:0006103) | 5.37553042 |
| 34 | short-chain fatty acid metabolic process (GO:0046459) | 5.36547311 |
| 35 | tricarboxylic acid metabolic process (GO:0072350) | 5.29487936 |
| 36 | aromatic amino acid family catabolic process (GO:0009074) | 5.22638603 |
| 37 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 5.21794903 |
| 38 | vitamin D metabolic process (GO:0042359) | 5.21027635 |
| 39 | tryptophan metabolic process (GO:0006568) | 5.19700373 |
| 40 | branched-chain amino acid metabolic process (GO:0009081) | 5.16333982 |
| 41 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 5.14421512 |
| 42 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 5.12933686 |
| 43 | drug catabolic process (GO:0042737) | 5.07999334 |
| 44 | urogenital system development (GO:0001655) | 5.05809137 |
| 45 | valine metabolic process (GO:0006573) | 5.05753843 |
| 46 | cilium or flagellum-dependent cell motility (GO:0001539) | 5.04028191 |
| 47 | toxin transport (GO:1901998) | 4.95819381 |
| 48 | modified amino acid transport (GO:0072337) | 4.92269247 |
| 49 | kynurenine metabolic process (GO:0070189) | 4.86744143 |
| 50 | homocysteine metabolic process (GO:0050667) | 4.85044414 |
| 51 | nephron tubule development (GO:0072080) | 4.82391772 |
| 52 | cilium movement (GO:0003341) | 4.80731292 |
| 53 | response to phenylpropanoid (GO:0080184) | 4.79114031 |
| 54 | L-phenylalanine metabolic process (GO:0006558) | 4.70605035 |
| 55 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.70605035 |
| 56 | amino-acid betaine transport (GO:0015838) | 4.68074954 |
| 57 | carnitine transport (GO:0015879) | 4.68074954 |
| 58 | positive regulation of gastrulation (GO:2000543) | 4.66613942 |
| 59 | exogenous drug catabolic process (GO:0042738) | 4.65939331 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 4.65286454 |
| 61 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.59724606 |
| 62 | L-phenylalanine catabolic process (GO:0006559) | 4.59724606 |
| 63 | nitric oxide mediated signal transduction (GO:0007263) | 4.56863970 |
| 64 | negative regulation of T cell differentiation in thymus (GO:0033085) | 4.54366989 |
| 65 | mesonephros development (GO:0001823) | 4.52759391 |
| 66 | acetyl-CoA metabolic process (GO:0006084) | 4.50045082 |
| 67 | glutamate metabolic process (GO:0006536) | 4.45664732 |
| 68 | peptide biosynthetic process (GO:0043043) | 4.42484179 |
| 69 | cellular modified amino acid catabolic process (GO:0042219) | 4.41970747 |
| 70 | epithelial cilium movement (GO:0003351) | 4.39694411 |
| 71 | axoneme assembly (GO:0035082) | 4.39600941 |
| 72 | motile cilium assembly (GO:0044458) | 4.37875377 |
| 73 | fructose metabolic process (GO:0006000) | 4.36971062 |
| 74 | phosphate ion homeostasis (GO:0055062) | 4.35254774 |
| 75 | trivalent inorganic anion homeostasis (GO:0072506) | 4.35254774 |
| 76 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 4.34906917 |
| 77 | branched-chain amino acid catabolic process (GO:0009083) | 4.30637245 |
| 78 | serine family amino acid metabolic process (GO:0009069) | 4.28907212 |
| 79 | parturition (GO:0007567) | 4.27518586 |
| 80 | amino-acid betaine metabolic process (GO:0006577) | 4.27458112 |
| 81 | renal tubule development (GO:0061326) | 4.25229189 |
| 82 | serine family amino acid catabolic process (GO:0009071) | 4.24971495 |
| 83 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.23768898 |
| 84 | fatty acid beta-oxidation (GO:0006635) | 4.21223328 |
| 85 | * calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.21188517 |
| 86 | embryonic epithelial tube formation (GO:0001838) | 4.16566233 |
| 87 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 4.16391607 |
| 88 | proline metabolic process (GO:0006560) | 4.16253904 |
| 89 | positive regulation of vesicle fusion (GO:0031340) | 4.09918781 |
| 90 | lens fiber cell development (GO:0070307) | 4.07038712 |
| 91 | carnitine metabolic process (GO:0009437) | 4.01959438 |
| 92 | fatty acid oxidation (GO:0019395) | 4.01468637 |
| 93 | ketone body metabolic process (GO:1902224) | 3.99994961 |
| 94 | ovulation from ovarian follicle (GO:0001542) | 3.99105501 |
| 95 | nephron epithelium development (GO:0072009) | 3.97372809 |
| 96 | negative regulation of kidney development (GO:0090185) | 3.97206893 |
| 97 | epithelial tube formation (GO:0072175) | 3.93737849 |
| 98 | lipid oxidation (GO:0034440) | 3.93656410 |
| 99 | cornea development in camera-type eye (GO:0061303) | 3.87388828 |
| 100 | vitamin transport (GO:0051180) | 3.86916254 |
| 101 | indolalkylamine metabolic process (GO:0006586) | 3.86578281 |
| 102 | aromatic amino acid family metabolic process (GO:0009072) | 3.85222660 |
| 103 | platelet dense granule organization (GO:0060155) | 3.80138357 |
| 104 | indole-containing compound metabolic process (GO:0042430) | 3.79068059 |
| 105 | glutathione derivative biosynthetic process (GO:1901687) | 3.77613244 |
| 106 | glutathione derivative metabolic process (GO:1901685) | 3.77613244 |
| 107 | glycoside metabolic process (GO:0016137) | 3.74254934 |
| 108 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 3.71150245 |
| 109 | positive regulation of metanephros development (GO:0072216) | 3.69218275 |
| 110 | cGMP-mediated signaling (GO:0019934) | 3.68370178 |
| 111 | mitochondrial calcium ion transport (GO:0006851) | 3.67636185 |
| 112 | cell-cell junction maintenance (GO:0045217) | 3.64529760 |
| 113 | peptide catabolic process (GO:0043171) | 3.63468636 |
| 114 | cellular amino acid catabolic process (GO:0009063) | 3.61904473 |
| 115 | transepithelial transport (GO:0070633) | 3.60847183 |
| 116 | amine catabolic process (GO:0009310) | 3.59981138 |
| 117 | cellular biogenic amine catabolic process (GO:0042402) | 3.59981138 |
| 118 | arginine catabolic process (GO:0006527) | 3.56669540 |
| 119 | glutathione metabolic process (GO:0006749) | 3.56348811 |
| 120 | NADH metabolic process (GO:0006734) | 3.55931113 |
| 121 | surfactant homeostasis (GO:0043129) | 3.53609155 |
| 122 | embryonic heart tube development (GO:0035050) | 3.53533339 |
| 123 | alpha-amino acid catabolic process (GO:1901606) | 3.52113206 |
| 124 | response to growth hormone (GO:0060416) | 3.51633773 |
| 125 | benzene-containing compound metabolic process (GO:0042537) | 3.50166617 |
| 126 | behavioral response to nicotine (GO:0035095) | 3.49160348 |
| 127 | interferon-gamma secretion (GO:0072643) | 3.48776774 |
| 128 | fatty acid catabolic process (GO:0009062) | 3.47627071 |
| 129 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 3.42327574 |
| 130 | L-ascorbic acid metabolic process (GO:0019852) | 3.42202623 |
| 131 | regulation of stem cell maintenance (GO:2000036) | 3.41811493 |
| 132 | biotin metabolic process (GO:0006768) | 3.39620261 |
| 133 | collecting duct development (GO:0072044) | 3.38921322 |
| 134 | endoderm formation (GO:0001706) | 3.37774772 |
| 135 | serine family amino acid biosynthetic process (GO:0009070) | 3.36566472 |
| 136 | sulfur amino acid catabolic process (GO:0000098) | 3.35272143 |
| 137 | cell volume homeostasis (GO:0006884) | 3.34721706 |
| 138 | oligosaccharide catabolic process (GO:0009313) | 3.33905763 |
| 139 | sodium ion transport (GO:0006814) | 3.32916507 |
| 140 | dicarboxylic acid metabolic process (GO:0043648) | 3.31515993 |
| 141 | positive regulation of hormone metabolic process (GO:0032352) | 3.31156756 |
| 142 | nephron tubule morphogenesis (GO:0072078) | 3.30720008 |
| 143 | nephron epithelium morphogenesis (GO:0072088) | 3.30720008 |
| 144 | sulfur compound transport (GO:0072348) | 3.30578218 |
| 145 | organic acid catabolic process (GO:0016054) | 3.28877480 |
| 146 | carboxylic acid catabolic process (GO:0046395) | 3.28877480 |
| 147 | left/right axis specification (GO:0070986) | 3.27995375 |
| 148 | neural tube formation (GO:0001841) | 3.27236693 |
| 149 | one-carbon compound transport (GO:0019755) | 3.24274769 |
| 150 | mesenchymal to epithelial transition (GO:0060231) | 3.23018469 |
| 151 | ear development (GO:0043583) | 3.20823510 |
| 152 | cell junction maintenance (GO:0034331) | 3.18349570 |
| 153 | protein-cofactor linkage (GO:0018065) | 3.15872939 |
| 154 | regulation of regulatory T cell differentiation (GO:0045589) | 3.14229957 |
| 155 | specification of organ identity (GO:0010092) | 3.12900665 |
| 156 | regulation of metanephros development (GO:0072215) | 3.11008022 |
| 157 | regulation of gastrulation (GO:0010470) | 3.08738408 |
| 158 | arginine metabolic process (GO:0006525) | 3.00501329 |
| 159 | cellular response to gonadotropin stimulus (GO:0071371) | 3.00113706 |
| 160 | regulation of mesoderm development (GO:2000380) | 2.95788621 |
| 161 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 2.84530810 |
| 162 | sodium-independent organic anion transport (GO:0043252) | 2.84409887 |
| 163 | L-fucose catabolic process (GO:0042355) | 2.82706028 |
| 164 | fucose catabolic process (GO:0019317) | 2.82706028 |
| 165 | L-fucose metabolic process (GO:0042354) | 2.82706028 |
| 166 | male meiosis I (GO:0007141) | 2.81570282 |
| 167 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 2.78015825 |
| 168 | regulation of hippo signaling (GO:0035330) | 2.77553858 |
| 169 | regulation of transcription involved in cell fate commitment (GO:0060850) | 2.74781317 |
| 170 | thyroid gland development (GO:0030878) | 2.74132429 |
| 171 | cytokine production involved in immune response (GO:0002367) | 2.72887904 |
| 172 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.72361443 |
| 173 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.66124035 |
| 174 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.63611472 |
| 175 | organelle disassembly (GO:1903008) | 2.62967826 |
| 176 | left/right pattern formation (GO:0060972) | 2.62687224 |
| 177 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.59005063 |
| 178 | cilium organization (GO:0044782) | 2.57586601 |
| 179 | positive regulation of mesonephros development (GO:0061213) | 2.53995092 |
| 180 | positive regulation of tolerance induction (GO:0002645) | 2.53164260 |
| 181 | regulation of mesonephros development (GO:0061217) | 2.53147620 |
| 182 | cardiovascular system development (GO:0072358) | 2.53101875 |
| 183 | inositol phosphate-mediated signaling (GO:0048016) | 2.50267258 |
| 184 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.49060636 |
| 185 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.45585847 |
| 186 | urate metabolic process (GO:0046415) | 10.1096448 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.28371722 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.47963543 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.96046638 |
| 4 | VDR_22108803_ChIP-Seq_LS180_Human | 3.73407513 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.51400637 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.36782497 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.35908550 |
| 8 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.28979569 |
| 9 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.98421594 |
| 10 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.84888268 |
| 11 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.71206721 |
| 12 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.69749001 |
| 13 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.69719145 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.53779369 |
| 15 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.45225846 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.44509884 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.39279477 |
| 18 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.23068748 |
| 19 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.19969879 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.17283277 |
| 21 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.15519729 |
| 22 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.94201695 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.82760326 |
| 24 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.82687549 |
| 25 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.82665236 |
| 26 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.76761063 |
| 27 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.74905077 |
| 28 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.72345442 |
| 29 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.67565177 |
| 30 | ERA_21632823_ChIP-Seq_H3396_Human | 1.67242341 |
| 31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.64659793 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.64304889 |
| 33 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.63058500 |
| 34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.59619887 |
| 35 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.56319388 |
| 36 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.53602745 |
| 37 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.51573882 |
| 38 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.48798709 |
| 39 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.47263589 |
| 40 | TP53_16413492_ChIP-PET_HCT116_Human | 1.45488001 |
| 41 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.43968760 |
| 42 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.41386546 |
| 43 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.40431460 |
| 44 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.39238486 |
| 45 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.37718645 |
| 46 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.37256912 |
| 47 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.35421293 |
| 48 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.35421293 |
| 49 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.35086419 |
| 50 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.33047017 |
| 51 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.32993193 |
| 52 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.32989267 |
| 53 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.32260185 |
| 54 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.32252683 |
| 55 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.30980341 |
| 56 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.29929457 |
| 57 | RXR_22108803_ChIP-Seq_LS180_Human | 1.29814010 |
| 58 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.29066373 |
| 59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28658798 |
| 60 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.27445565 |
| 61 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.26868001 |
| 62 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.24363404 |
| 63 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.24005600 |
| 64 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.23706807 |
| 65 | P300_19829295_ChIP-Seq_ESCs_Human | 1.23366372 |
| 66 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.20484493 |
| 67 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20078071 |
| 68 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.19024640 |
| 69 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.17916076 |
| 70 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.16590769 |
| 71 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.15793295 |
| 72 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.14489487 |
| 73 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.14031911 |
| 74 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.13759393 |
| 75 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.12743575 |
| 76 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.12378045 |
| 77 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.11805836 |
| 78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.11552873 |
| 79 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.10274089 |
| 80 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.09021002 |
| 81 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.06935726 |
| 82 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.04649126 |
| 83 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04185847 |
| 84 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.03743022 |
| 85 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.02338878 |
| 86 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.01857526 |
| 87 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.01200154 |
| 88 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.01067296 |
| 89 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00452460 |
| 90 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.99838716 |
| 91 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.99799236 |
| 92 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99623173 |
| 93 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.99168791 |
| 94 | NCOR_22424771_ChIP-Seq_293T_Human | 0.98615002 |
| 95 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.98488823 |
| 96 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.98100379 |
| 97 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.97820369 |
| 98 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97590501 |
| 99 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.96818589 |
| 100 | * MYC_19829295_ChIP-Seq_ESCs_Human | 0.96684594 |
| 101 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.95700484 |
| 102 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95616208 |
| 103 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.95571240 |
| 104 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.95571240 |
| 105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95011080 |
| 106 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.94901167 |
| 107 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.94299503 |
| 108 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94283459 |
| 109 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.94084561 |
| 110 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.94073166 |
| 111 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.92190520 |
| 112 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.92189184 |
| 113 | AR_25329375_ChIP-Seq_VCAP_Human | 0.90935753 |
| 114 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90187545 |
| 115 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.89256157 |
| 116 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.87803807 |
| 117 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.87457745 |
| 118 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86985001 |
| 119 | * P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.86449913 |
| 120 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.86154934 |
| 121 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.86067808 |
| 122 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.85695465 |
| 123 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.85695465 |
| 124 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.85299258 |
| 125 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.83699122 |
| 126 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.82432169 |
| 127 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 0.81894843 |
| 128 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.81471052 |
| 129 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.81048673 |
| 130 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.80944299 |
| 131 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.80729770 |
| 132 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.80574425 |
| 133 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.80533902 |
| 134 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.80347784 |
| 135 | TCF4_23295773_ChIP-Seq_U87_Human | 0.79935356 |
| 136 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.79904954 |
| 137 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.79714134 |
| 138 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.79637065 |
| 139 | SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.79555046 |
| 140 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.79508737 |
| 141 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.79483433 |
| 142 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79177182 |
| 143 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.79131340 |
| 144 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.79041224 |
| 145 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.79041224 |
| 146 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.78868950 |
| 147 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.78542492 |
| 148 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.77990654 |
| 149 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.77528364 |
| 150 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.77233520 |
| 151 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.77233520 |
| 152 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.76817173 |
| 153 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.75883624 |
| 154 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.75458418 |
| 155 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.75368216 |
| 156 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.75270910 |
| 157 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.74637538 |
| 158 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.72099512 |
| 159 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.71530460 |
| 160 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.71333093 |
| 161 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.70900972 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.95880637 |
| 2 | MP0004043_abnormal_pH_regulation | 7.16813187 |
| 3 | MP0003195_calcinosis | 5.12500598 |
| 4 | MP0005332_abnormal_amino_acid | 5.07240439 |
| 5 | MP0005645_abnormal_hypothalamus_physiol | 4.42675675 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 4.08572818 |
| 7 | * MP0004019_abnormal_vitamin_homeostasis | 4.02874636 |
| 8 | * MP0009643_abnormal_urine_homeostasis | 3.94923563 |
| 9 | MP0001756_abnormal_urination | 3.83479265 |
| 10 | * MP0001765_abnormal_ion_homeostasis | 3.76037361 |
| 11 | MP0002138_abnormal_hepatobiliary_system | 3.64381953 |
| 12 | MP0002277_abnormal_respiratory_mucosa | 3.48478598 |
| 13 | MP0006292_abnormal_olfactory_placode | 3.21910663 |
| 14 | * MP0005636_abnormal_mineral_homeostasis | 3.02113947 |
| 15 | * MP0002136_abnormal_kidney_physiology | 2.94178765 |
| 16 | MP0005377_hearing/vestibular/ear_phenot | 2.92645523 |
| 17 | MP0003878_abnormal_ear_physiology | 2.92645523 |
| 18 | MP0008875_abnormal_xenobiotic_pharmacok | 2.75004265 |
| 19 | MP0001502_abnormal_circadian_rhythm | 2.73139554 |
| 20 | MP0002160_abnormal_reproductive_system | 2.58557833 |
| 21 | MP0005646_abnormal_pituitary_gland | 2.47367901 |
| 22 | MP0005083_abnormal_biliary_tract | 2.42707607 |
| 23 | MP0003938_abnormal_ear_development | 2.41053428 |
| 24 | MP0003183_abnormal_peptide_metabolism | 2.31257325 |
| 25 | MP0001958_emphysema | 2.28052376 |
| 26 | MP0005365_abnormal_bile_salt | 2.20081782 |
| 27 | MP0002909_abnormal_adrenal_gland | 2.17992374 |
| 28 | MP0003252_abnormal_bile_duct | 2.17931566 |
| 29 | MP0008961_abnormal_basal_metabolism | 2.09473276 |
| 30 | MP0000049_abnormal_middle_ear | 2.06253669 |
| 31 | MP0001501_abnormal_sleep_pattern | 2.04147475 |
| 32 | MP0004885_abnormal_endolymph | 2.03917204 |
| 33 | MP0005503_abnormal_tendon_morphology | 2.02123160 |
| 34 | MP0000538_abnormal_urinary_bladder | 1.96392014 |
| 35 | MP0004133_heterotaxia | 1.93441685 |
| 36 | MP0005085_abnormal_gallbladder_physiolo | 1.92973140 |
| 37 | MP0005389_reproductive_system_phenotype | 1.91523544 |
| 38 | MP0000013_abnormal_adipose_tissue | 1.87555268 |
| 39 | MP0008872_abnormal_physiological_respon | 1.84216200 |
| 40 | MP0005451_abnormal_body_composition | 1.78898305 |
| 41 | MP0005058_abnormal_lysosome_morphology | 1.74434772 |
| 42 | MP0000631_abnormal_neuroendocrine_gland | 1.73934973 |
| 43 | MP0000372_irregular_coat_pigmentation | 1.71704862 |
| 44 | MP0004858_abnormal_nervous_system | 1.66707463 |
| 45 | MP0002102_abnormal_ear_morphology | 1.62653966 |
| 46 | MP0000566_synostosis | 1.55492454 |
| 47 | MP0001881_abnormal_mammary_gland | 1.54589103 |
| 48 | MP0000681_abnormal_thyroid_gland | 1.54490343 |
| 49 | MP0002876_abnormal_thyroid_physiology | 1.54322295 |
| 50 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.51565580 |
| 51 | MP0003186_abnormal_redox_activity | 1.51007674 |
| 52 | MP0002254_reproductive_system_inflammat | 1.45937308 |
| 53 | MP0003045_fibrosis | 1.35840567 |
| 54 | MP0000230_abnormal_systemic_arterial | 1.32341148 |
| 55 | MP0003936_abnormal_reproductive_system | 1.31323909 |
| 56 | MP0002177_abnormal_outer_ear | 1.30041409 |
| 57 | MP0002168_other_aberrant_phenotype | 1.29508259 |
| 58 | MP0001919_abnormal_reproductive_system | 1.22981605 |
| 59 | MP0003300_gastrointestinal_ulcer | 1.22630344 |
| 60 | MP0009046_muscle_twitch | 1.21729435 |
| 61 | MP0010030_abnormal_orbit_morphology | 1.20937001 |
| 62 | MP0005084_abnormal_gallbladder_morpholo | 1.20288521 |
| 63 | MP0005319_abnormal_enzyme/_coenzyme | 1.20185158 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 1.16296928 |
| 65 | MP0002135_abnormal_kidney_morphology | 1.16175948 |
| 66 | MP0005535_abnormal_body_temperature | 1.15462603 |
| 67 | MP0005551_abnormal_eye_electrophysiolog | 1.15418202 |
| 68 | MP0003283_abnormal_digestive_organ | 1.11361195 |
| 69 | MP0006036_abnormal_mitochondrial_physio | 1.10821796 |
| 70 | MP0000383_abnormal_hair_follicle | 1.09890303 |
| 71 | MP0003806_abnormal_nucleotide_metabolis | 1.08005272 |
| 72 | MP0003646_muscle_fatigue | 1.07704113 |
| 73 | MP0002928_abnormal_bile_duct | 1.04577438 |
| 74 | MP0002127_abnormal_cardiovascular_syste | 1.01915134 |
| 75 | MP0001666_abnormal_nutrient_absorption | 1.00247935 |
| 76 | MP0002837_dystrophic_cardiac_calcinosis | 0.98160332 |
| 77 | MP0002272_abnormal_nervous_system | 0.97882022 |
| 78 | MP0004147_increased_porphyrin_level | 0.97293383 |
| 79 | MP0003136_yellow_coat_color | 0.97172938 |
| 80 | MP0009780_abnormal_chondrocyte_physiolo | 0.96338298 |
| 81 | MP0002557_abnormal_social/conspecific_i | 0.95742184 |
| 82 | MP0000685_abnormal_immune_system | 0.93534992 |
| 83 | MP0005670_abnormal_white_adipose | 0.93529942 |
| 84 | MP0001764_abnormal_homeostasis | 0.92126824 |
| 85 | MP0010234_abnormal_vibrissa_follicle | 0.90996726 |
| 86 | MP0002733_abnormal_thermal_nociception | 0.89791322 |
| 87 | MP0002184_abnormal_innervation | 0.89713545 |
| 88 | MP0003315_abnormal_perineum_morphology | 0.86778363 |
| 89 | MP0008775_abnormal_heart_ventricle | 0.85762362 |
| 90 | MP0009745_abnormal_behavioral_response | 0.84806994 |
| 91 | MP0002638_abnormal_pupillary_reflex | 0.84647785 |
| 92 | MP0008995_early_reproductive_senescence | 0.83731046 |
| 93 | MP0001944_abnormal_pancreas_morphology | 0.82735558 |
| 94 | MP0005395_other_phenotype | 0.82464645 |
| 95 | MP0001661_extended_life_span | 0.82375028 |
| 96 | MP0005253_abnormal_eye_physiology | 0.82128289 |
| 97 | MP0003943_abnormal_hepatobiliary_system | 0.81743398 |
| 98 | MP0002089_abnormal_postnatal_growth/wei | 0.80643434 |
| 99 | MP0004264_abnormal_extraembryonic_tissu | 0.80232338 |
| 100 | MP0001663_abnormal_digestive_system | 0.80193504 |
| 101 | MP0000639_abnormal_adrenal_gland | 0.78920878 |
| 102 | MP0002118_abnormal_lipid_homeostasis | 0.78464623 |
| 103 | MP0004742_abnormal_vestibular_system | 0.78067024 |
| 104 | MP0005666_abnormal_adipose_tissue | 0.77908328 |
| 105 | MP0003638_abnormal_response/metabolism_ | 0.77592420 |
| 106 | MP0002896_abnormal_bone_mineralization | 0.76668663 |
| 107 | MP0001873_stomach_inflammation | 0.74652354 |
| 108 | MP0003959_abnormal_lean_body | 0.73192731 |
| 109 | MP0000467_abnormal_esophagus_morphology | 0.72832848 |
| 110 | MP0001986_abnormal_taste_sensitivity | 0.71921037 |
| 111 | MP0003890_abnormal_embryonic-extraembry | 0.71367634 |
| 112 | MP0001905_abnormal_dopamine_level | 0.71200229 |
| 113 | MP0002249_abnormal_larynx_morphology | 0.69949335 |
| 114 | MP0002064_seizures | 0.69759226 |
| 115 | MP0001485_abnormal_pinna_reflex | 0.69728870 |
| 116 | MP0002877_abnormal_melanocyte_morpholog | 0.69722717 |
| 117 | * MP0009642_abnormal_blood_homeostasis | 0.67776996 |
| 118 | MP0002796_impaired_skin_barrier | 0.67206773 |
| 119 | MP0008789_abnormal_olfactory_epithelium | 0.66897541 |
| 120 | MP0000534_abnormal_ureter_morphology | 0.65051327 |
| 121 | MP0003329_amyloid_beta_deposits | 0.64887431 |
| 122 | MP0009333_abnormal_splenocyte_physiolog | 0.64759697 |
| 123 | MP0000470_abnormal_stomach_morphology | 0.62341402 |
| 124 | MP0002572_abnormal_emotion/affect_behav | 0.60619250 |
| 125 | MP0002736_abnormal_nociception_after | 0.58607187 |
| 126 | MP0004084_abnormal_cardiac_muscle | 0.58053838 |
| 127 | MP0001968_abnormal_touch/_nociception | 0.56865914 |
| 128 | MP0009379_abnormal_foot_pigmentation | 0.56682460 |
| 129 | MP0010386_abnormal_urinary_bladder | 0.53764441 |
| 130 | MP0005220_abnormal_exocrine_pancreas | 0.53555755 |
| 131 | MP0003879_abnormal_hair_cell | 0.51258631 |
| 132 | MP0010329_abnormal_lipoprotein_level | 0.51213866 |
| 133 | MP0002069_abnormal_eating/drinking_beha | 0.49369655 |
| 134 | MP0009764_decreased_sensitivity_to | 0.48683221 |
| 135 | MP0000747_muscle_weakness | 0.48512060 |
| 136 | MP0004272_abnormal_basement_membrane | 0.48115010 |
| 137 | MP0001963_abnormal_hearing_physiology | 0.47334875 |
| 138 | MP0000678_abnormal_parathyroid_gland | 0.46650093 |
| 139 | MP0003172_abnormal_lysosome_physiology | 0.46251773 |
| 140 | MP0000609_abnormal_liver_physiology | 0.45332082 |
| 141 | MP0005165_increased_susceptibility_to | 0.45065237 |
| 142 | MP0001177_atelectasis | 0.44042640 |
| 143 | MP0005408_hypopigmentation | 0.43197608 |
| 144 | MP0002098_abnormal_vibrissa_morphology | 0.43019843 |
| 145 | MP0005501_abnormal_skin_physiology | 0.42711169 |
| 146 | MP0003795_abnormal_bone_structure | 0.41755793 |
| 147 | MP0004484_altered_response_of | 0.41574089 |
| 148 | MP0002078_abnormal_glucose_homeostasis | 0.41558598 |
| 149 | MP0008469_abnormal_protein_level | 0.41412125 |
| 150 | MP0002115_abnormal_skeleton_extremities | 0.39654567 |
| 151 | MP0001270_distended_abdomen | 0.37343440 |
| 152 | MP0000598_abnormal_liver_morphology | 0.36114277 |
| 153 | MP0003221_abnormal_cardiomyocyte_apopto | 0.35566699 |
| 154 | MP0001727_abnormal_embryo_implantation | 0.34466414 |
| 155 | MP0000920_abnormal_myelination | 0.31788063 |
| 156 | * MP0003953_abnormal_hormone_level | 0.31084543 |
| 157 | MP0000371_diluted_coat_color | 0.30849133 |
| 158 | MP0000163_abnormal_cartilage_morphology | 0.30806623 |
| 159 | MP0001664_abnormal_digestion | 0.30528677 |
| 160 | MP0006035_abnormal_mitochondrial_morpho | 0.29266470 |
| 161 | MP0004233_abnormal_muscle_weight | 0.27552880 |
| 162 | MP0000026_abnormal_inner_ear | 0.27544423 |
| 163 | MP0002998_abnormal_bone_remodeling | 0.27332652 |
| 164 | MP0000751_myopathy | 0.26542460 |
| 165 | MP0001731_abnormal_postnatal_growth | 0.26390180 |
| 166 | MP0005166_decreased_susceptibility_to | 0.25878674 |
| 167 | MP0003075_altered_response_to | 0.25848113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Metabolic alkalosis (HP:0200114) | 8.88220990 |
| 2 | Increased circulating renin level (HP:0000848) | 8.68203378 |
| 3 | Hypokalemic alkalosis (HP:0001949) | 8.56685088 |
| 4 | Hyperactive renin-angiotensin system (HP:0000841) | 7.89130734 |
| 5 | Abnormality of chloride homeostasis (HP:0011422) | 7.31175390 |
| 6 | * Hypomagnesemia (HP:0002917) | 7.19297798 |
| 7 | Gout (HP:0001997) | 7.13894518 |
| 8 | * Polyuria (HP:0000103) | 7.01524465 |
| 9 | * Abnormal urine output (HP:0012590) | 6.60985590 |
| 10 | * Abnormality of renal excretion (HP:0011036) | 6.09744187 |
| 11 | * Abnormality of magnesium homeostasis (HP:0004921) | 5.99992028 |
| 12 | Thyroid-stimulating hormone excess (HP:0002925) | 5.81922227 |
| 13 | Renal salt wasting (HP:0000127) | 5.80348302 |
| 14 | Hypothermia (HP:0002045) | 5.72094033 |
| 15 | Hyperaldosteronism (HP:0000859) | 5.66805361 |
| 16 | Abnormality of renin-angiotensin system (HP:0000847) | 5.37096463 |
| 17 | Alkalosis (HP:0001948) | 5.32633595 |
| 18 | * Abnormal drinking behavior (HP:0030082) | 5.17823830 |
| 19 | * Polydipsia (HP:0001959) | 5.17823830 |
| 20 | Proximal tubulopathy (HP:0000114) | 4.98580630 |
| 21 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.82750774 |
| 22 | * Tetany (HP:0001281) | 4.67310852 |
| 23 | Hyperglycinuria (HP:0003108) | 4.65907465 |
| 24 | Abnormal respiratory motile cilium morphology (HP:0005938) | 4.55196637 |
| 25 | Abnormal respiratory epithelium morphology (HP:0012253) | 4.55196637 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.49182980 |
| 27 | * Increased purine levels (HP:0004368) | 4.42570729 |
| 28 | * Hyperuricemia (HP:0002149) | 4.42570729 |
| 29 | Split foot (HP:0001839) | 4.35741653 |
| 30 | Abnormal respiratory motile cilium physiology (HP:0012261) | 4.35123154 |
| 31 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.26923566 |
| 32 | Absent/shortened dynein arms (HP:0200106) | 4.26923566 |
| 33 | Hypokalemia (HP:0002900) | 4.21708967 |
| 34 | Abnormal ciliary motility (HP:0012262) | 4.21117190 |
| 35 | Fibular aplasia (HP:0002990) | 3.95405703 |
| 36 | Rhinitis (HP:0012384) | 3.90636111 |
| 37 | Ketoacidosis (HP:0001993) | 3.90154531 |
| 38 | Abnormality of glycine metabolism (HP:0010895) | 3.76812421 |
| 39 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.76812421 |
| 40 | * Abnormality of purine metabolism (HP:0004352) | 3.74944013 |
| 41 | Chronic bronchitis (HP:0004469) | 3.74502148 |
| 42 | Generalized aminoaciduria (HP:0002909) | 3.51304926 |
| 43 | * Hypercalciuria (HP:0002150) | 3.48326658 |
| 44 | Abnormality of midbrain morphology (HP:0002418) | 3.48115432 |
| 45 | Molar tooth sign on MRI (HP:0002419) | 3.48115432 |
| 46 | Abnormality of potassium homeostasis (HP:0011042) | 3.46885104 |
| 47 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 3.42465085 |
| 48 | Pancreatic cysts (HP:0001737) | 3.25739618 |
| 49 | Ketosis (HP:0001946) | 3.23682720 |
| 50 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.23435095 |
| 51 | Humeroradial synostosis (HP:0003041) | 3.20233819 |
| 52 | Synostosis involving the elbow (HP:0003938) | 3.20233819 |
| 53 | Abnormality of urine glucose concentration (HP:0011016) | 3.14588492 |
| 54 | Glycosuria (HP:0003076) | 3.14588492 |
| 55 | Congenital stationary night blindness (HP:0007642) | 3.02587346 |
| 56 | Abnormality of sodium homeostasis (HP:0010931) | 3.00800732 |
| 57 | Pancreatic fibrosis (HP:0100732) | 2.99287487 |
| 58 | Focal segmental glomerulosclerosis (HP:0000097) | 2.94448508 |
| 59 | Chronic hepatic failure (HP:0100626) | 2.91641839 |
| 60 | Hyperphosphaturia (HP:0003109) | 2.91411069 |
| 61 | Bell-shaped thorax (HP:0001591) | 2.85716877 |
| 62 | Stomach cancer (HP:0012126) | 2.81564148 |
| 63 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.76216892 |
| 64 | Hyponatremia (HP:0002902) | 2.71732064 |
| 65 | Abnormality of proline metabolism (HP:0010907) | 2.71729549 |
| 66 | Hydroxyprolinuria (HP:0003080) | 2.71729549 |
| 67 | Abnormal urine phosphate concentration (HP:0012599) | 2.71195019 |
| 68 | True hermaphroditism (HP:0010459) | 2.69462514 |
| 69 | Bronchiectasis (HP:0002110) | 2.66544712 |
| 70 | Dehydration (HP:0001944) | 2.66029706 |
| 71 | Delayed CNS myelination (HP:0002188) | 2.64056640 |
| 72 | * Abnormality of nucleobase metabolism (HP:0010932) | 2.62735843 |
| 73 | Adrenal overactivity (HP:0002717) | 2.62191998 |
| 74 | Delayed epiphyseal ossification (HP:0002663) | 2.56231061 |
| 75 | Barrel-shaped chest (HP:0001552) | 2.54044207 |
| 76 | * Renal tubular acidosis (HP:0001947) | 2.53153780 |
| 77 | * Nephrocalcinosis (HP:0000121) | 2.50442928 |
| 78 | Spinal muscular atrophy (HP:0007269) | 2.50306043 |
| 79 | Abnormality of the vertebral endplates (HP:0005106) | 2.46954027 |
| 80 | Abnormality of the renal medulla (HP:0100957) | 2.44597833 |
| 81 | Conical tooth (HP:0000698) | 2.42278447 |
| 82 | Hyperglycinemia (HP:0002154) | 2.41425721 |
| 83 | * Nephrolithiasis (HP:0000787) | 2.34546162 |
| 84 | Hypophosphatemia (HP:0002148) | 2.34023784 |
| 85 | Nephronophthisis (HP:0000090) | 2.33966087 |
| 86 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.33789838 |
| 87 | Tubular atrophy (HP:0000092) | 2.32441432 |
| 88 | Vomiting (HP:0002013) | 2.29268120 |
| 89 | Chondrocalcinosis (HP:0000934) | 2.24223188 |
| 90 | Metabolic acidosis (HP:0001942) | 2.23994165 |
| 91 | Cystic liver disease (HP:0006706) | 2.22755984 |
| 92 | Facial shape deformation (HP:0011334) | 2.20971296 |
| 93 | Potter facies (HP:0002009) | 2.20971296 |
| 94 | Rickets (HP:0002748) | 2.20222166 |
| 95 | Confusion (HP:0001289) | 2.20205937 |
| 96 | Dicarboxylic aciduria (HP:0003215) | 2.19963593 |
| 97 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.19963593 |
| 98 | Chronic otitis media (HP:0000389) | 2.16982286 |
| 99 | Vascular calcification (HP:0004934) | 2.16834958 |
| 100 | Vacuolated lymphocytes (HP:0001922) | 2.16460947 |
| 101 | Oligodactyly (hands) (HP:0001180) | 2.16055006 |
| 102 | Enlarged kidneys (HP:0000105) | 2.16044445 |
| 103 | Stage 5 chronic kidney disease (HP:0003774) | 2.16040877 |
| 104 | Tubulointerstitial fibrosis (HP:0005576) | 2.15074653 |
| 105 | Decreased circulating renin level (HP:0003351) | 2.13026216 |
| 106 | Hyperammonemia (HP:0001987) | 2.12795045 |
| 107 | Widely patent fontanelles and sutures (HP:0004492) | 2.12409004 |
| 108 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.12152663 |
| 109 | Abnormality of Sharpey fibers (HP:0100685) | 2.11923825 |
| 110 | Absence seizures (HP:0002121) | 2.11584514 |
| 111 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.10474533 |
| 112 | Enlarged epiphyses (HP:0010580) | 2.10360027 |
| 113 | Goiter (HP:0000853) | 2.10210870 |
| 114 | Abnormality of the pubic bones (HP:0003172) | 2.04294328 |
| 115 | Large for gestational age (HP:0001520) | 2.03743645 |
| 116 | Metaphyseal cupping (HP:0003021) | 2.02625348 |
| 117 | Abnormality of renal resorption (HP:0011038) | 1.99057461 |
| 118 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.98951885 |
| 119 | Hypotension (HP:0002615) | 1.98660004 |
| 120 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.96493440 |
| 121 | Congenital hepatic fibrosis (HP:0002612) | 1.95532128 |
| 122 | Hyperventilation (HP:0002883) | 1.95325021 |
| 123 | Decreased central vision (HP:0007663) | 1.93530715 |
| 124 | Abnormality of the renal cortex (HP:0011035) | 1.93460566 |
| 125 | Malnutrition (HP:0004395) | 1.93317404 |
| 126 | Male pseudohermaphroditism (HP:0000037) | 1.92822753 |
| 127 | Occipital encephalocele (HP:0002085) | 1.92682333 |
| 128 | Cardiovascular calcification (HP:0011915) | 1.91957073 |
| 129 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.91644402 |
| 130 | Lethargy (HP:0001254) | 1.88556822 |
| 131 | Degeneration of anterior horn cells (HP:0002398) | 1.86762446 |
| 132 | Abnormality of the anterior horn cell (HP:0006802) | 1.86762446 |
| 133 | Tachypnea (HP:0002789) | 1.86456693 |
| 134 | Stridor (HP:0010307) | 1.85506749 |
| 135 | Hypoplasia of the radius (HP:0002984) | 1.84772250 |
| 136 | Anencephaly (HP:0002323) | 1.84414012 |
| 137 | Hypoplastic iliac wings (HP:0002866) | 1.84260939 |
| 138 | Bicornuate uterus (HP:0000813) | 1.81353480 |
| 139 | Generalized muscle weakness (HP:0003324) | 1.79979039 |
| 140 | Amelogenesis imperfecta (HP:0000705) | 1.78544426 |
| 141 | Methylmalonic aciduria (HP:0012120) | 1.78001451 |
| 142 | Dialeptic seizures (HP:0011146) | 1.77881024 |
| 143 | Neonatal onset (HP:0003623) | 1.77168590 |
| 144 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.77103008 |
| 145 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.76881624 |
| 146 | Glomerulosclerosis (HP:0000096) | 1.76540679 |
| 147 | Adactyly (HP:0009776) | 1.75283818 |
| 148 | Athetosis (HP:0002305) | 1.73384307 |
| 149 | Abnormal tarsal ossification (HP:0008369) | 1.73096581 |
| 150 | Irritability (HP:0000737) | 1.72639614 |
| 151 | Hoarse voice (HP:0001609) | 1.72100957 |
| 152 | Morphological abnormality of the middle ear (HP:0008609) | 1.69895692 |
| 153 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.69458914 |
| 154 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.68966588 |
| 155 | Medial flaring of the eyebrow (HP:0010747) | 1.68859098 |
| 156 | Diaphragmatic weakness (HP:0009113) | 1.68073738 |
| 157 | Type II lissencephaly (HP:0007260) | 1.67563406 |
| 158 | Aplasia/Hypoplasia of the fibula (HP:0006492) | 1.66397892 |
| 159 | Pendular nystagmus (HP:0012043) | 1.66291177 |
| 160 | Polygenic inheritance (HP:0010982) | 1.66064034 |
| 161 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.66015275 |
| 162 | Macroglossia (HP:0000158) | 1.65054517 |
| 163 | Aplasia/Hypoplasia of the ulna (HP:0006495) | 1.64421757 |
| 164 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.63215921 |
| 165 | Nausea (HP:0002018) | 1.62524856 |
| 166 | Thin bony cortex (HP:0002753) | 1.62371689 |
| 167 | Abnormality of carpal bone ossification (HP:0006257) | 1.61816303 |
| 168 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.61362346 |
| 169 | Abnormal eating behavior (HP:0100738) | 1.54873940 |
| 170 | * Renal tubular dysfunction (HP:0000124) | 1.54605390 |
| 171 | Lymphangioma (HP:0100764) | 1.49449351 |
| 172 | Axonal loss (HP:0003447) | 1.48805891 |
| 173 | Hyperkalemia (HP:0002153) | 1.47670552 |
| 174 | Metaphyseal dysplasia (HP:0100255) | 1.44904755 |
| 175 | Hypophosphatemic rickets (HP:0004912) | 1.44714989 |
| 176 | Metaphyseal irregularity (HP:0003025) | 1.44057969 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 9.92775370 |
| 2 | OXSR1 | 8.12264564 |
| 3 | WNK4 | 7.84605836 |
| 4 | TLK1 | 4.60851045 |
| 5 | STK39 | 3.98680555 |
| 6 | TAOK3 | 3.01329780 |
| 7 | EPHA2 | 2.53148357 |
| 8 | BCKDK | 2.44371214 |
| 9 | FRK | 2.30805877 |
| 10 | STK38L | 2.26403371 |
| 11 | ADRBK2 | 2.15275373 |
| 12 | SGK494 | 1.89691890 |
| 13 | SGK223 | 1.89691890 |
| 14 | NEK2 | 1.89125441 |
| 15 | WNK1 | 1.83230475 |
| 16 | EPHA3 | 1.81925414 |
| 17 | NEK1 | 1.68196949 |
| 18 | IKBKE | 1.64356042 |
| 19 | PDK4 | 1.63892164 |
| 20 | PDK3 | 1.63892164 |
| 21 | GRK1 | 1.41224728 |
| 22 | PDK2 | 1.39360319 |
| 23 | FGFR2 | 1.33455851 |
| 24 | NME1 | 1.24372287 |
| 25 | SGK2 | 1.21929745 |
| 26 | IRAK4 | 1.19139132 |
| 27 | PKN1 | 1.17257906 |
| 28 | MKNK2 | 1.16116477 |
| 29 | SGK3 | 1.15503409 |
| 30 | NTRK2 | 1.14227444 |
| 31 | STK38 | 1.11070078 |
| 32 | MST4 | 0.95621844 |
| 33 | MAP4K2 | 0.93430640 |
| 34 | CAMK1 | 0.92799390 |
| 35 | MST1R | 0.90047877 |
| 36 | IRAK1 | 0.88076921 |
| 37 | VRK1 | 0.87096900 |
| 38 | NUAK1 | 0.86698760 |
| 39 | ADRBK1 | 0.84283630 |
| 40 | MAPKAPK3 | 0.83085681 |
| 41 | PINK1 | 0.81036308 |
| 42 | STK24 | 0.80381685 |
| 43 | LRRK2 | 0.79716010 |
| 44 | ZAK | 0.76592856 |
| 45 | MAP2K7 | 0.75123340 |
| 46 | CHUK | 0.72108955 |
| 47 | IKBKB | 0.71867751 |
| 48 | TIE1 | 0.68247495 |
| 49 | ERBB2 | 0.67426752 |
| 50 | TBK1 | 0.66158527 |
| 51 | EIF2AK2 | 0.65159556 |
| 52 | GRK6 | 0.65156133 |
| 53 | BMPR1B | 0.64500298 |
| 54 | DAPK2 | 0.64331540 |
| 55 | LIMK1 | 0.63116365 |
| 56 | MARK2 | 0.62793528 |
| 57 | DYRK2 | 0.62269045 |
| 58 | MAP3K4 | 0.60945172 |
| 59 | MAPKAPK5 | 0.58941087 |
| 60 | ABL2 | 0.58163858 |
| 61 | PRKCE | 0.58097612 |
| 62 | GSK3A | 0.57249105 |
| 63 | EPHB1 | 0.56898960 |
| 64 | SGK1 | 0.56801393 |
| 65 | PRKCG | 0.56793612 |
| 66 | CAMK4 | 0.55768577 |
| 67 | FGFR4 | 0.55386655 |
| 68 | MAPK13 | 0.53984492 |
| 69 | CAMK2A | 0.53519841 |
| 70 | PTK2 | 0.53061134 |
| 71 | ILK | 0.52979812 |
| 72 | PRKAA1 | 0.50698568 |
| 73 | STK3 | 0.46898965 |
| 74 | PTK2B | 0.46413778 |
| 75 | SIK2 | 0.46097580 |
| 76 | STK10 | 0.45603916 |
| 77 | FER | 0.44595781 |
| 78 | RPS6KA6 | 0.44503815 |
| 79 | MAP2K6 | 0.44332911 |
| 80 | MAP3K7 | 0.44168742 |
| 81 | ERBB4 | 0.44003627 |
| 82 | CSF1R | 0.42885156 |
| 83 | RPS6KA5 | 0.41667197 |
| 84 | MET | 0.41049663 |
| 85 | MKNK1 | 0.40922231 |
| 86 | NTRK1 | 0.39069245 |
| 87 | EPHA4 | 0.38953175 |
| 88 | PAK3 | 0.38125231 |
| 89 | DMPK | 0.38059571 |
| 90 | PNCK | 0.37420001 |
| 91 | PDPK1 | 0.36727013 |
| 92 | MAP3K9 | 0.35662683 |
| 93 | PRKACB | 0.35575297 |
| 94 | CDK7 | 0.35516499 |
| 95 | ERN1 | 0.34192703 |
| 96 | MINK1 | 0.33822364 |
| 97 | TGFBR2 | 0.33249998 |
| 98 | PRKCI | 0.33034962 |
| 99 | PRKAA2 | 0.31817163 |
| 100 | PAK4 | 0.30970551 |
| 101 | MAP3K3 | 0.30763904 |
| 102 | AKT3 | 0.29084428 |
| 103 | PIK3CA | 0.28282182 |
| 104 | DYRK1B | 0.26569897 |
| 105 | PRKD2 | 0.25335049 |
| 106 | PRKCZ | 0.23753248 |
| 107 | MAPK11 | 0.23249638 |
| 108 | KSR2 | 0.23220860 |
| 109 | PDK1 | 0.22060217 |
| 110 | PTK6 | 0.19084921 |
| 111 | PRKCD | 0.18876914 |
| 112 | MAP3K6 | 0.18664309 |
| 113 | MAP3K2 | 0.17026928 |
| 114 | CSNK1G1 | 0.16841780 |
| 115 | MAP3K13 | 0.16151546 |
| 116 | INSRR | 0.15034059 |
| 117 | KSR1 | 0.14632698 |
| 118 | EPHB2 | 0.14180644 |
| 119 | PRKACA | 0.13799411 |
| 120 | PRKACG | 0.13450435 |
| 121 | SCYL2 | 0.12597437 |
| 122 | ROCK1 | 0.12474791 |
| 123 | MAPK15 | 0.11852017 |
| 124 | PRKCA | 0.11788163 |
| 125 | ROCK2 | 0.11659548 |
| 126 | PRKCQ | 0.11407429 |
| 127 | TRIB3 | 0.10805627 |
| 128 | CSNK1A1 | 0.10546420 |
| 129 | AKT2 | 0.10207669 |
| 130 | MYLK | 0.10034898 |
| 131 | JAK2 | 0.09439367 |
| 132 | PRKCH | 0.08718688 |
| 133 | TTK | 0.07908954 |
| 134 | MAP2K4 | 0.07071724 |
| 135 | BMPR2 | 0.06834032 |
| 136 | LMTK2 | 0.06673582 |
| 137 | STK11 | 0.06188948 |
| 138 | CDK5 | 0.04633137 |
| 139 | PIM1 | 0.04269796 |
| 140 | LATS1 | 0.04158438 |
| 141 | PAK6 | 0.03264943 |
| 142 | MAP3K14 | 0.02433959 |
| 143 | PRKD3 | 0.02125990 |
| 144 | BMX | 0.02041815 |
| 145 | MOS | 0.01478928 |
| 146 | MAP2K1 | 0.01240250 |
| 147 | LATS2 | 0.01161092 |
| 148 | SRC | 0.01136067 |
| 149 | IGF1R | 0.00848086 |
| 150 | RIPK4 | 0.00495512 |
| 151 | MARK3 | -0.0083129 |
| 152 | PDGFRA | -0.0068895 |
| 153 | CDK19 | -0.0046044 |
| 154 | INSR | -0.0030304 |
| 155 | CSNK1G2 | -0.0012464 |
| 156 | CSNK1A1L | -0.0007905 |
| 157 | MAP3K8 | -0.0007692 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 4.01361886 |
| 2 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.88575694 |
| 3 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.66871885 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.56917430 |
| 5 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 3.54783775 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.43077425 |
| 7 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.27171903 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.22428668 |
| 9 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 3.21397089 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.18891702 |
| 11 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.84542709 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.73131178 |
| 13 | Phototransduction_Homo sapiens_hsa04744 | 2.72415027 |
| 14 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.64328962 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.46294097 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.40025174 |
| 17 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.33706831 |
| 18 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 2.32704113 |
| 19 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.32118963 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.26475671 |
| 21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.24132815 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.22333008 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.20901359 |
| 24 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.16983404 |
| 25 | Salivary secretion_Homo sapiens_hsa04970 | 2.13402755 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.09519571 |
| 27 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.09484826 |
| 28 | Bile secretion_Homo sapiens_hsa04976 | 1.87903061 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.84346305 |
| 30 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.82210878 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.81465557 |
| 32 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.71842554 |
| 33 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.69560418 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.68682270 |
| 35 | Carbon metabolism_Homo sapiens_hsa01200 | 1.66270035 |
| 36 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.65353334 |
| 37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.64146744 |
| 38 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.61187085 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.47783287 |
| 40 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.44861792 |
| 41 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.43660505 |
| 42 | Mineral absorption_Homo sapiens_hsa04978 | 1.41024242 |
| 43 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.37150604 |
| 44 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.36344316 |
| 45 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.31241845 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.29994415 |
| 47 | Lysine degradation_Homo sapiens_hsa00310 | 1.29962850 |
| 48 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.26944901 |
| 49 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.23310747 |
| 50 | RNA polymerase_Homo sapiens_hsa03020 | 1.18616183 |
| 51 | Basal transcription factors_Homo sapiens_hsa03022 | 1.13920571 |
| 52 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.13892134 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 1.13649506 |
| 54 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.13401263 |
| 55 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.11031239 |
| 56 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.05471574 |
| 57 | Nicotine addiction_Homo sapiens_hsa05033 | 1.05320116 |
| 58 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.05150065 |
| 59 | * Tight junction_Homo sapiens_hsa04530 | 1.02995212 |
| 60 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.97071496 |
| 61 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.96827123 |
| 62 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.94451044 |
| 63 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.92661685 |
| 64 | Homologous recombination_Homo sapiens_hsa03440 | 0.88374082 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.87961423 |
| 66 | Ribosome_Homo sapiens_hsa03010 | 0.87431386 |
| 67 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.86881473 |
| 68 | Circadian entrainment_Homo sapiens_hsa04713 | 0.85118260 |
| 69 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.83957467 |
| 70 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.81206876 |
| 71 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.80250195 |
| 72 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78769680 |
| 73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.78644506 |
| 74 | Histidine metabolism_Homo sapiens_hsa00340 | 0.78377667 |
| 75 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.77880729 |
| 76 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.77840916 |
| 77 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.77326170 |
| 78 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.76751209 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.75625918 |
| 80 | Cocaine addiction_Homo sapiens_hsa05030 | 0.73783324 |
| 81 | Circadian rhythm_Homo sapiens_hsa04710 | 0.73393622 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69878636 |
| 83 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.67586960 |
| 84 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66352323 |
| 85 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.66058939 |
| 86 | Asthma_Homo sapiens_hsa05310 | 0.65437541 |
| 87 | Taste transduction_Homo sapiens_hsa04742 | 0.65023199 |
| 88 | Lysosome_Homo sapiens_hsa04142 | 0.60334590 |
| 89 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.59598319 |
| 90 | Morphine addiction_Homo sapiens_hsa05032 | 0.56889984 |
| 91 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56164286 |
| 92 | Olfactory transduction_Homo sapiens_hsa04740 | 0.56147828 |
| 93 | Parkinsons disease_Homo sapiens_hsa05012 | 0.55689020 |
| 94 | * Hepatitis C_Homo sapiens_hsa05160 | 0.52580737 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.51930899 |
| 96 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.50584771 |
| 97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.50267357 |
| 98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49740801 |
| 99 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.47668286 |
| 100 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.43297802 |
| 101 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.42095947 |
| 102 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.42065508 |
| 103 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41875797 |
| 104 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.39300205 |
| 105 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.38770543 |
| 106 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35975915 |
| 107 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.34591241 |
| 108 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.32521963 |
| 109 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.32080183 |
| 110 | Purine metabolism_Homo sapiens_hsa00230 | 0.32074286 |
| 111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.31469734 |
| 112 | Insulin secretion_Homo sapiens_hsa04911 | 0.31145495 |
| 113 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.30854054 |
| 114 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.30830293 |
| 115 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.30829770 |
| 116 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.29971108 |
| 117 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29955325 |
| 118 | Alzheimers disease_Homo sapiens_hsa05010 | 0.29070176 |
| 119 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.26201128 |
| 120 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.25343929 |
| 121 | Retinol metabolism_Homo sapiens_hsa00830 | 0.25285481 |
| 122 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.24705258 |
| 123 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.23283498 |
| 124 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.22922654 |
| 125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.22034345 |
| 126 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.21667950 |
| 127 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.19460596 |
| 128 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.16699406 |
| 129 | Sulfur relay system_Homo sapiens_hsa04122 | 0.16410523 |
| 130 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.14508594 |
| 131 | Huntingtons disease_Homo sapiens_hsa05016 | 0.12952901 |
| 132 | ABC transporters_Homo sapiens_hsa02010 | 0.10207737 |
| 133 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.07529328 |
| 134 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.05918443 |
| 135 | Bladder cancer_Homo sapiens_hsa05219 | 0.05281060 |
| 136 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.04128311 |
| 137 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.02497817 |
| 138 | Insulin resistance_Homo sapiens_hsa04931 | 0.02217322 |
| 139 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.00138128 |
| 140 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | -0.1059769 |
| 141 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0936370 |
| 142 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0825267 |
| 143 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0786260 |
| 144 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | -0.0520665 |
| 145 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0201520 |
| 146 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | -0.0137156 |

